New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01482104
Recruitment Status : Completed
First Posted : November 30, 2011
Last Update Posted : October 27, 2017
Akershus Dermatological Centre
Helse Stavanger HF
Oslo University Hospital
Førde Central Hospital
Haukeland University Hospital
Hudlegekontoret Lillehammer
Hudlegene på Holtet DA
Information provided by (Responsible Party):
Norwegian University of Science and Technology

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2017
  Actual Study Completion Date : October 2017